<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
><channel><title>Коментари на: Pismo zdravstvenim radnicima o ograničenju indikacije za lek Tecentriq (atezolizumab)▼</title><atom:link href="http://mediscopia.com/pismo-zdravstvenim-radnicima-o-ogranicenju-indikacije-za-lek-tecentriq-atezolizumab%E2%96%BC/feed/" rel="self" type="application/rss+xml" /><link>http://mediscopia.com/pismo-zdravstvenim-radnicima-o-ogranicenju-indikacije-za-lek-tecentriq-atezolizumab%e2%96%bc/</link><description>Za stručnu medicinsku javnost</description><lastBuildDate>Sun, 26 Aug 2018 09:26:31 +0000</lastBuildDate><sy:updatePeriod>hourly</sy:updatePeriod><sy:updateFrequency>1</sy:updateFrequency><generator>https://wordpress.org/?v=7.0.1</generator></channel></rss>